Stocks Fall from Early Highs as Chipmakers Retreat
Stocks slipped from early highs as chipmakers and AI-infrastructure shares fell. The iShares Semiconductor ETF (SOXX) fell over 3%, with Sandisk (SNDK) down more than 11% and AMD and Western Digital down over 6%. Crude dropped about 6%, lifting T-notes and lowering 10-year breakeven inflation. Software stocks rose; Workday gained over 8%.
How this was made
The 30-second read
Why it matters
Crude oil’s 6% plunge is cited as easing inflation expectations, but the equity response is still negative for semis and energy, indicating investors are trading growth-duration and sector positioning rather than only inflation relief.
Market read
This is a same-day cross-asset and sector rotation read-through, with several single-name catalysts (trial miss, M&A, analyst coverage, earnings beat) that can drive intraday and near-term positioning.
What to watch
The article lists many movers but only a few provide company-specific catalysts; traders should avoid assuming the same driver applies across all down names.
Background
The piece frames US weakness as part of a broader rates and commodity move, with chipmakers retreating while software and certain single-name catalysts rally.
Ticker impact
Sandisk (SNDK) is down more than 11% to lead losers in the S&P 500 and Nasdaq 100.
Elevated volatility and continued weakness likely until a specific catalyst is identified.
The text gives magnitude and ranking but does not disclose the underlying driver beyond the sector retreat framing.
Advanced Micro Devices (AMD) is down more than 6% as chipmakers and AI-infrastructure stocks retreat.
Short-term pressure likely to persist with semis until rates stabilize.
The article explicitly groups AMD with other chipmakers falling on the same day.
Western Digital (WDC) is down more than 6% alongside other chipmakers retreating today.
Near-term downside bias consistent with the group move.
The article provides the move magnitude but no separate WDC-specific catalyst.
Nvidia (NVDA) is down more than 4% after announcing a substantial investment in AI startup Safe Superintelligence.
Potential for continued selling if investors interpret the investment as dilution of focus or execution risk.
The article states the investment and the stock reaction but does not provide investor rationale or follow-on details.
ConocoPhillips (COP) is down more than 2% as energy producers slide with the 6% plunge in crude oil prices.
Further weakness possible if crude remains under pressure.
The article directly links the energy selloff to the same-day crude decline.
MapLight Therapeutics (MPLT) is down more than 64% after mid-stage schizophrenia trial results did not meet the upside case.
High volatility and likely continued downside until clearer next-step data or guidance emerges.
The article provides a concrete clinical-trial outcome and an analyst framing (did not meet upside case).
Workday (WDAY) is up more than 8% to lead gainers as software stocks rally.
Relative strength likely to persist while the market seeks growth exposure outside semis.
The article reports the move but does not cite a WDAY-specific catalyst beyond the sector rally.
Forte Biosciences (FBRX) is up more than 39% after Argenx SE agreed to buy it for about $2.2 billion.
Supportive near-term bid behavior, with upside dependent on deal terms and regulatory/closing risk.
The article includes deal size and per-share price, which are typically sufficient to drive immediate repricing.
Market effects
Semiconductors and AI-infrastructure are the main drag, while software and select growth/biotech are providing offset.
Overseas markets are higher, but US chip and energy weakness is dominating the tape despite firmer European/Asian closes.
Crude oil’s sharp drop is feeding into bond/inflation expectations and translating into cross-asset risk repricing.
Counterpoint
The semis weakness may be more about today’s macro tape (rates and oil) than deteriorating fundamentals, so selling could be overdone if crude stabilizes.
Key entities
- ETFSOXX
Semiconductor ETF down more than 3% as chipmakers retreat.
- EquityNVDA
Nvidia down more than 4% after announcing a substantial investment in Safe Superintelligence.
- EquityMPLT
MapLight Therapeutics down more than 64% after mid-stage schizophrenia trial missed the upside case.
- EquityFBRX
Forte Biosciences up more than 39% on an agreed acquisition by Argenx for about $2.2B.
- EquityBKR
Baker Hughes up more than 6% after Q2 revenue beat versus consensus.
